Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2025-06-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025
Regulatory Filings Classification · 92% confidence The document is HKEX Form FF301 "Monthly Return for Equity Issuer and Hong Kong Depositary Receipts" under Chapter 19B listing rules. It provides detailed monthly movements in authorized/issued share capital, treasury shares, convertibles, and confirmations under the Exchange Listing Rules. This is a routine regulatory filing specific to share capital movements with no earnings, management discussion, or presentation format. It does not match annual reports, interim reports, capital-raising updates (it’s a periodic share movement return rather than a financing announcement), or other specific categories. It therefore falls under the fallback category for miscellaneous regulatory filings.
2025-06-02 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING ON TUESDAY, 24 JUNE 2025
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Form of Proxy for the company’s Annual General Meeting, used to solicit voting instructions from shareholders and appoint proxies. This type of document falls under materials sent to shareholders requesting votes for a meeting, matching the definition of a Proxy Solicitation & Information Statement (PSI). It is not an AGM presentation, voting result announcement, or the actual AGM minutes. Therefore, it should be classified as PSI.
2025-05-20 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a formal notice convening the Annual General Meeting, outlining meeting details, resolutions to be voted on, and proxy appointment instructions. It is not the AGM presentation materials (AGM-R) nor the results, but rather the solicitation of proxies and information for shareholder voting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-05-20 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a shareholder circular for Sisram Medical Ltd’s upcoming Annual General Meeting, including the notice of meeting, resolutions for re-election of directors, share buy-back and issuance mandates, proxy arrangements and detailed appendices. It is not the full annual report or financial statements, nor merely an announcement. Rather, it is a proxy solicitation/information statement circulated to shareholders ahead of the AGM to request votes. Therefore it matches our Proxy Solicitation & Information Statement category (PSI).
2025-05-20 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE EXTENSION OF LOAN
Capital/Financing Update Classification · 84% confidence The document is a formal Hong Kong Stock Exchange announcement describing a discloseable transaction under Chapter 14 of the Listing Rules: the extension of a HK$17 million loan maturity by one year. This is a financing activity update rather than a full report, earnings release, share transaction, or legal notice. It details the terms of the loan extension and listing rule implications, fitting squarely under “Capital/Financing Update.”
2025-05-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings Classification · 93% confidence The document is a prescribed monthly return (Form FF301) submitted under HKEX Listing Rules Chapter 19B, detailing month-end movements in authorized and issued share capital and confirming no share option, warrant, or convertible movements. It is a routine regulatory compliance filing to the exchange rather than an investor presentation, earnings release, or standalone financial report. There is no issuance or repurchase transaction to classify as a share issue or buyback notice. The content fits best into the general Regulatory Filings (RNS) category as a fallback for miscellaneous compliance submissions.
2025-05-06 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.